Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Completed
Eli Lilly and Company
Phase 3
2003-06-01
This is a multicenter, comparator-controlled, open-label, randomized, two-arm, parallel trial
to compare the effect of exenatide twice daily and insulin glargine on glycemic control, as
measured by hemoglobin A1c (HbA1c).
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Completed
AstraZeneca
Phase 3
2003-06-01
This is a multicenter, comparator-controlled, open-label, randomized, two-arm, parallel trial
to compare the effect of exenatide twice daily and insulin glargine on glycemic control, as
measured by hemoglobin A1c (HbA1c).
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
Completed
Eli Lilly and Company
Phase 3
2003-11-01
This is a Phase 3, multicenter, open-label, comparator-controlled trial comparing the effect
of exenatide twice daily to twice daily biphasic insulin aspart on glycemic control, as
measured by hemoglobin A1c (HbA1c).
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
